Skip to content

Clinical trials

Heart Failure trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Country / region: United Arab Emirates Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20141
20161
20181
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Enrolling by invitation1
No longer available1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Novartis Pharmaceuticals2
Abbott Medical Devices1
European Society of Cardiology1
McMaster University1
Medtronic Cardiac Rhythm and Heart Failure1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Prashant Nasa1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure10
Atrial Fibrillation1
Bradycardia1
Diabetes Mellitus, Type 21
Heart Diseases1
Hypertension1
Influenza, Human1
Renal Insufficiency, Chronic1
Respiratory Distress Syndrome1
Respiratory Insufficiency1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.